Perelman School of Medicine at the University of Pennsylvania

Cardiovascular Institute (CVI)

Upcoming Seminars and Workshops

 

CVI Seminar Series


Weekly seminars hosted by the CVI

Fall 2020

All CVI Seminars for Fall 2020 will be held at 4:00 PM virtually via BlueJeans. Click the link below to enter the event:
https://primetime.bluejeans.com/a2m/live-event/zpdrxfdw

 

September 2020


Kiran Musunuru, M.D., Ph.D., M.P.H., M.L.

Perelman School of Medicine
September 16, 2020

Vinicio de Jesus Perez, M.D.

Stanford University Medical Center
September 23, 2020

Joshua Wythe, Ph.D.

Baylor College of Medicine
September 30, 2020

 

October 2020


Leslie Leinwand, Ph.D.

Colorado University Denver School of Medicine
October 7, 2020

Elizabeth Murphy, Ph.D.

NHLBI
October 14, 2020

William Pu, M.D.

Harvard Medical school & Boston Children's Hospital
October 28, 2020

 

November 2020


Martin Young, Ph.D.

The University of Alabama at Birmingham
November 4, 2020

Jennifer Davis, Ph.D.

University of Washington
November 11, 2020

Arndt Siekmann, Ph.D.

Perelman School of Medicine
November 18, 2020

 

December 2020


Marcus Goncalves, M.D., Ph.D.

Cornell University
December 2, 2020

Sharlene Day, M.D.

Perelman School of Medicine
December 9, 2020

Benoit Bruneau, Ph.D.

Gladstone Institute of Cardiovascular Disease
December 16, 2020

 

Close


Past Seminars

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

 

A


Zoltan Arany, M.D., Ph.D.

Perelman School of Medicine
New Players in Mitophagy
December 12, 2018

Euan Ashley, M.D.

Stanford University
1 to 100,000 Single Cells to Populations in Cardiovascular Genomics
February 28, 2018

 

B


Robert Balaban, Ph.D.

National Heart, Lung, and Blood Institute
The Mitochondria Reticulum of Muscle Cells
December 11, 2019

Gerd Blobel, M.D., Ph.D.

Perelman School of Medicine
Genome and Epigenome Editing to Treat Hemoglobinopathies
March 14, 2018

Laurie Boyer, Ph.D.

Massachusetts Institute of Technology
Programming and Reprogramming Cardiac Cell Fate
January 31, 2018

Paul Burridge, Ph.D.

Northwestern University
Pharmacogenomic Prediction and Prevention of  Chemotherapy-Induced Cardiotoxicity using hiPSC
January 16, 2019

 

C


Thomas Cappola, M.D., Sc.M.

Perelman School of Medicine
Crossing the Translational Divide in Heart Failure
November 20, 2019

Kathleen Caron, Ph.D.

UNC-Chapel Hill
GPCR Regulation of Lymphatics in Health and Disease
February 13, 2019

Mete Civelek, Ph.D.

University of Virginia
Genetic Regulation of Vascular Smooth Muscle Cell Function
March 4, 2020

Kieran Clarke, Ph.D.

University of Oxford
A Ketone Drink for Heart Failure?
February 27, 2019

Kareen Coulombe, Ph.D.

Brown University
Re-Engineering Myocardium for Heart Regeneration
January 29, 2020

Peter Crawford, M.D., Ph.D.

University of Minnesota
Following Ketone Carbon Through Macrophages, Landing in Hepatic Fibrogenesis
January 30, 2019

 

D


 

E


Patrick Ellinor, M.D., Ph.D.

Massachusetts General Hospital
Atrial Fibrillation from Genetics to Mechanisms
March 6, 2019

John Elrod, Ph.D.

Lewis Katz School of Medicine at Temple University
Mitochondrial Calcium Signaling in Cardiac Physiology and Disease
February 7, 2018

 

F


Jason Fish, Ph.D.

University Toronto
Decoding the Non-coding Regulatory Pathways of Vascular Inflammation
October 3, 2018

Mark Fishman, M.D.

Massachusetts General Hospital
Genetic Architecture of Social Behavior in Zebrafish
May 9, 2018

Garret FitzGerald, M.D.

Perelman School of Medicine
Cardiovascular Hazard and NSAIDs
November 1, 2017

David Frank, M.D., Ph.D.

Children's Hospital of Philadelphia
Defining Mechanisms of Cardiopulmonary Cell Fate for Pediatric Pulmonary Hypertension Therapy
December 20, 2017

Sarah Franklin, Ph.D.

University of Utah School of Medicine
The Lysine Methyltransferase Smyd1 Regulates Growth and Metabolism in the Heart
September 25, 2019

 

G


Anna Gelzer D.V.M., Ph.D.

School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020

Guillermo Garcia-Cardena, Ph.D.

Brigham and Women’s Hospital, Boston
Novel Drivers of Endothelial Cell Dysfunction
April 10, 2019

Brian Glancy, Ph.D.

NHLBI
The Muscle Mitochondrial Reticulum
May 2, 2018

David Glass, M.D.

Regeneron Pharmaceuticals, Inc. & Harvard Medical School
Molecular Mechanisms of Aging, Including in Skeletal Muscle
January 15, 2020

Ira Goldberg, M.D.

New York University Langone Health
Feeding the Heart with Fat
October 30, 2019

Robert Gorman, M.D.

Perelman School of Medicine
Post-MI LV Remodeling: An Engineering Perspective with Implications for Regenerative Therapies
January 24, 2018

Daniel Greif, M.D.

Yale University School of Medicine
Vascular Mural Cells in Development and Disease
May 1, 2019

Courtney Griffin, Ph.D.

University of Oklahoma Health Sciences Center
Exploiting Chromatin-Remodeling Complexes to Study Vascular Development and Maintenance
May 15, 2019

Asa Gustafsson, Ph.D.

Skaggs School of Pharmacy and Pharmaceutical Sciences
Novel Mechanisms of Mitochondrial Quality Control in the Heart
December 19, 2018

 

H


Timothy Hla, Ph.D.

Boston Children's Hospital
Novel Insights into Endothelial GPCR Regulation of Transcriptional Mechanisms of Angiogenesis and Organotypic Specialization
February 5, 2020

Priscilla Hsue, M.D.

UCSF School of Medicine
HIV Infection, Inflammation and Cardiovascular Disease: 2018 Update
December 5, 2018

 

I


Erik Ingelsson M.D., Ph.D., F.A.H.A.

Stanford University
Ten Years and Hundreds of Novel Cardiovascular Loci: What Now?
May 16, 2018

 

J


Rajan Jain, M.D.

Perelman School of Medicine
Understanding How Genome Organization Regulates Cardiac Development and Disease
February 6, 2019

 

K


Mark Kahn, M.D.

Perelman School of Medicine
Valve Hemodynamics in Development and Disease
January 17, 2018

David Kass, M.D.

John Hopkins University School of Medicine
How PKG Regulates Protein Quality Control
December 4, 2019

Daniel Kelly, M.D.

Perelman School of Medicine
Fuel Metabolic Checkpoints as Targets for Cardiovascular Disease
October 4, 2017

Richard Kitsis, M.D.

Albert Einstein College of Medicine
Chemical and Structural Approaches to Manipulating Cell Death
November 7, 2018

Marc Kraus, D.V.M.

School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020

Calvin Kuo, M.D., Ph.D.

Stanford University School of Medicine
Molecular Regulation of the Blood-Brain Barrier
April 4, 2018

 

L


Kory Lavine, M.D., Ph.D.

Washington University School of Medicine in St. Louis
Leveraging Immune Cell Diversity in the Failing Heart
October 23, 2019

Mitchell Lazar, M.D., Ph.D.

Perelman School of Medicine
Transcriptional Regulation of Metabolism
November 29, 2017

Nicholas Leeper, M.D.

Stanford University School of Medicine
The Role of Efferocytosis in Cardiovascular Disease
September 19, 2018

Merry Lindsey, Ph.D.

University of Mississippi
Cardiac Remodeling After Myocardial Infarction
October 2, 2019

 

M


Andy Marks, M.D.

Columbia University
What Makes the Heart Pump: High Resolution Structure and Function of the Ryanodine Receptor
October 18, 2017

James Martin, M.D., Ph.D.

Baylor College of Medicine
Hippo Signaling in Heart Regeneration
January 10, 2018

Megan McCain, Ph.D.

University of Southern California
Engineering "Heart on a Chip" Platforms for Cardiac Disease Modeling
March 13, 2019

Tim McKinsey, Ph.D.

University of Colorado Denver - Anschutz Medical Campus
Protein Acetylation in Heart Failure: The Epigenome and Beyond
April 11, 2018

Jeffery Molkentin, Ph.D.

Cincinnati Children’s Hospital Medical Center
An Acute Immune Response Underlies the Benefit of Cardiac Adult Stem Cell Therapy
April 3, 2019

Edward Morrisey, Ph.D.

Perelman School of Medicine
Ensuring the Cardiovascular System Has Something to Work With: Building and Rebuilding the Lungs
March 20, 2019

Deborah Muoio, Ph.D.

Duke University Medical Center
Integrating Molecular Phenomics and Respiratory Fluxomics to Decipher the Metabolic Basis of Heart Failure
October 24, 2018

Kiran Musunuru, M.D., Ph.D.

Perelman School of Medicine
Discovery and Therapeutic Genome Editing of Coronary Heart Disease Genes
December 6, 2017

 

N


Matthias Nahrendorf, M.D., Ph.D.

Massachusetts General Hospital
Innate Immunity and Cardiovascular Health
October 16, 2019

Stefania Nicoli, Ph.D.

Yale School of Medicine
RNA Mechanisms Governing Endothelial Cell Behaviors in Development and Homeostasis
January 22, 2020

 

O


Mark Oyama, D.V.M., M.S.C.E.

School of Veterinary School of Medicine
Spontaneous Models of Arrhythmogenic, Cardiomyopathic, and Valvular Disease
February 12, 2020

 

P


Kit Parker, Ph.D.

Harvard University
Designing, Building, and Testing Muscular Pumps
February 20, 2019

Liming Pei, Ph.D.

Perelman School of Medicine
Listen to your Heart
December 13, 2017

Jorge Plutzky, M.D.

Harvard Medical School
Joint IDOM/CVI Seminar
May 22, 2019

Michael Potente, M.D.

Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany
Metabolic Regulation of Endothelial Growth State
October 9, 2019

Benjamin Prosser, Ph.D.

Perelman School of Medicine
Cardiomyocyte Mechanobiology in Health and Heart Failure
September 26, 2018

 

Q


 

R


Daniel Rader, M.D.

Perelman School of Medicine
New Biology in Cardiometabolic Traits Revealed Through Human Genetics
November 8, 2017

Kristy Red-Horse, Ph.D.

Stanford University
Building and Rebuilding the Heart: Coronary Artery Development and Regeneration
January 23, 2019

Howard Rockman, M.D.

Duke University School of Medicine
Biased G Protein-Coupled Receptor Signaling
March 27, 2019

 

S


Michael Sacks, Ph.D.

The University of Texas at Austin
Multi-Resolution Models of the Mitral Heart Valve: From Mechanobiology to Surgical Repair
October 31, 2018

Vijay Sankaran, M.D., Ph.D.

Broad Institute of MIT and Harvard
Genetic Studies of Human Hematopoiesis
November 28, 2018

Sydney Shaffer, M.D., Ph.D.

Perelman School of Medicine
Making Sense of Transcriptional Heterogeneity in Rare Cells
February 19, 2020

Shey-Shing Sheu, Ph.D., F.A.H.A.

Thomas Jefferson University
Defeating Heart Failure with Energy: Mechanisms of Cardiac Excitation-Contraction-Energetics Coupling
October 10, 2018

Raymond Soccio, M.D., Ph.D.

Perelman School of Medicine
Genetics of Gene Regulation by PPAR Nuclear Receptors in Cardiometabolic Disease
May 23, 2018

Didier Stainier, Ph.D.

Max Planck Institute for Heart and Lung Research
Biological Robustness: Genetic Compensation and Transcriptional Adaptation
February 26, 2020

Matthew Steinhauser, M.D.

Brigham and Women’s Hospital, Division of Cardiovascular Medicine
White Adipose Plasticity and Systemic Insulin Resistance
November 13, 2019

Katalin Susztak, M.D., Ph.D.

Perelman School of Medicine
APOL1: The Balance Imposed by Infection, Selection, Kidney and Cardiovascular Disease
May 8, 2019

 

T


Ira Tabas, M.D., Ph.D.

Columbia University Irving Medical Center
Macrophage Metabolism in Atherosclerosis
September 3, 2019

Alan Tall, M.D.

Columbia University
Lipids, Hematopoiesis and Athero-Thrombosis
February 14, 2018

Rong Tian, M.D., Ph.D.

University of Washington
Is Metabolism a Driver in Pathological Remodeling of the Heart?
March 7, 2018

 

U


 

V


Benjamin Voight, Ph.D.

Perelman School of Medicine
One Shot, One Opportunity: Making it Count with Computational Human Genomics
October 25, 2017

Tom Vondriska, Ph.D.

UCLA
Epigenomics of Cardiovascular Disease
April 24, 2019

 

W


Douglas Wallace, Ph.D.

Hospital of the University of Pennsylvania
A Mitochondrial Etiology of Complex Diseases
October 11, 2017

Kenneth Walsh, Ph.D.

Boston University School of Medicine
Somatic Mutations, Clonal Hematopoiesis and Cardio-metabolic Risk
Jamuary 3, 2018

Yibin Wang, Ph.D.

UCLA David Geffen School of Medicine
Common Pathway in Cardiometabolic Regulation: Signaling Beyond Bioenergetics
April 25, 2018

Hao Wu, Ph.D.

 Perelman School of Medicine
Decoding Human Ventricular Cardiomyocyte Specification and Maturation with Integrated Cell-Type Specific Epigenomic and Transcriptomic Analysis
October 17, 2018

 

X


 

Y


 

Z


 

 

Close


TRIPS Series (Trainee Research in Progress Seminar Series)

All Trips Seminars are held virtually via the link below:

https://bluejeans.com/741347201

 

September 8, 2020 @12pm

 

Aileen Ren, BA

Kahn Laboratory
Downstream Mechanisms of Vascular Malformation

Joseph Park, BA

Rader Laboratory
Exome Wide Evaluation of Rare Coding Variants Using Electronic Health Record Data to Identify Novel Gene Phenotype Associations

 


October 20, 2020 @12pm

 

Emily Scarborough, PhD

Prosser Laboratory
Microtubules Enable Cardiac Growth Via Localization of mRNA and Translational Machinery

Katherine Quiroz-Figueroa BS

Rader Laboratory
Hepatic TRIB1 Regulates LDL Metabolism Through CEBPα - Mediated Regulation of the LDL Receptor

 


November 10, 2020 @12pm

 

Ingrid Marti-Pamies, PhD

Scherrer-Crosbie Laboratory
Brown Adipose Tissue and Cardioprotection : Targeting BMP3b on Myocardial Ischemia Reperfusion

Natasha Jaiswal, PhD

Titchenell Laboratory
Akt Regulates Muscle Growth and Function via Coordinated Regulation of mTORC1 and FoxO1

 


December 8, 2020 @12pm

 

Thomas Keller, PhD

Kahn Laboratory
Lymphangiogenesis is not Required for Recovery from Myocardial Infarction

Ling Lai, MD, PhD

Kelly Laboratory
Delineating the Upstream Regulators of PGC 1a in Melanoma Using Functional Genomic Screens

 


Close


Workshops

Note: All workshops are RSVP REGISTRATION ONLY as seats are limited. Contact Emily Schuster (emily.schuster@pennmedicine.upenn.edu) for more information.

Tuesday, November 27, 2018 12pm, Smilow 11-146AB

CRISPR-Cas9 Genome Editing Bootcamp (Advanced Level)

Dr. Kiran Musunuru
 

Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The advanced-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which base editing, epigenome editing, and other advanced concepts are explored (requiring participants to bring their own WiFi-capable laptops).


 

Tuesday, September 18, 2018 12pm, Smilow 11-146AB

CRISPR-Cas9 Genome Editing Bootcamp (Basic Level)

Dr. Kiran Musunuru
 

Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The basic-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which knockout/knock-in mice and cell lines are generated (requiring participants to bring their own WiFi-capable laptops). Participants will learn online tools to design CRISPR-Cas9 reagents, common pitfalls to avoid, and interpreting data from genome-editing experiments.

 

Monday, May 14, 2018 12pm, Smilow 11-146AB

CRISPR-Cas9 Genome Editing Bootcamp (Advanced Level)

Dr. Kiran Musunuru
 

Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The advanced-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which base editing, epigenome editing, and other advanced concepts are explored (requiring participants to bring their own WiFi-capable laptops).

 

Tuesday, January 23, 2018 12pm, Smilow 11-146AB

CRISPR-Cas9 Genome Editing Bootcamp (Basic Level)

Dr. Kiran Musunuru
 

Genome-editing tools, particularly CRISPR-Cas9, are transforming biomedical investigation. This practical, hands-on workshop, organized by the CVI Genetic and Epigenetic Origins of Disease (GEODe) Program, is intended for anybody interested in learning how to use CRISPR-Cas9-based technologies. The basic-level workshop will follow a flipped-classroom, active-learning model. Participants will review an online video/slides before the meeting. In the workshop, participants will work in teams on virtual experiments in which knockout/knock-in mice and cell lines are generated (requiring participants to bring their own WiFi-capable laptops). Participants will learn online tools to design CRISPR-Cas9 reagents, common pitfalls to avoid, and interpreting data from genome-editing experiments.

Close


 

CV Grand Rounds